drugset
drugset / Trial / NCT04858308

Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.

NCT04858308 ↗

Phase 3 Unknown 554 enrolled Yooyoung Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase 3 study to evaluate the effiacay and safety of YYC506

Timeline

Start
2021-01-29
Primary completion
2021-05-31
Completion
2022-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator YYC506 Unknown — —

Indications

hyperlipidemia